File Download
  Patent History
  • Application
    PC T/US2007080013 2007-09-28
  • Publication
    WO 2008040027 2008-04-03
  Patent Family

Patent: DIRECTED DIFFRENTIATION AND MATURATION OF STEM CELL-DERIVED CARDIOMYOCYTES

TitleDIRECTED DIFFRENTIATION AND MATURATION OF STEM CELL-DERIVED CARDIOMYOCYTES
Priority Date2006-09-28 US 11/848114P
2006-09-28 US 11/848159P
Inventors
Issue Date2008
Citation
WO Published patent application WO 2008040027. World Intellectual Property Organization (WIPO), PatentScope, 2008 How to Cite?
AbstractThis invention provides an isolated electrophysiologically immature cell or its derivative that has been modified to provide a mature electrophysiological phenotype and populations of these cells. Compositions containing these cells and populations of cells are also provided by this invention. These cells and compositions have therapeutic and diagnostic uses. Non-limiting therapeutic uses include regenerating cardiac tissue, improving cardiac function, restoring action potential of cardiac tissue; and treating or preventing cardiac malfunction. The cells and population of cells also can be used diagnostically to screen drug or other therapeutic candidate.
Persistent Identifierhttp://hdl.handle.net/10722/195294
References

 

DC FieldValueLanguage
dc.date.accessioned2014-02-26T06:16:57Z-
dc.date.available2014-02-26T06:16:57Z-
dc.date.issued2008-
dc.identifier.citationWO Published patent application WO 2008040027. World Intellectual Property Organization (WIPO), PatentScope, 2008en_US
dc.identifier.urihttp://hdl.handle.net/10722/195294-
dc.description.abstractThis invention provides an isolated electrophysiologically immature cell or its derivative that has been modified to provide a mature electrophysiological phenotype and populations of these cells. Compositions containing these cells and populations of cells are also provided by this invention. These cells and compositions have therapeutic and diagnostic uses. Non-limiting therapeutic uses include regenerating cardiac tissue, improving cardiac function, restoring action potential of cardiac tissue; and treating or preventing cardiac malfunction. The cells and population of cells also can be used diagnostically to screen drug or other therapeutic candidate.en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documentsen_US
dc.titleDIRECTED DIFFRENTIATION AND MATURATION OF STEM CELL-DERIVED CARDIOMYOCYTESen_US
dc.typePatent-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorLI, RONALDen_US
dc.contributor.inventorSIU, DAVID CWen_US
patents.identifier.applicationPC T/US2007080013en_US
patents.description.assigneeUNIV CALIFORNIA [US]; LI RONALD [US]; SIU DAVID CW [US]en_US
patents.description.countryWorld Intellectual Property Organization (WIPO)en_US
patents.date.publication2008-04-03en_US
dc.relation.referencesUS 2005244377 (A1) 2005-11-03en_US
dc.relation.referencesUS 2004033943 (A1) 2004-02-19en_US
dc.relation.referencesUS 2006128647 (A1) 2006-06-15en_US
patents.date.application2007-09-28en_US
patents.date.priority2006-09-28 US 11/848114Pen_US
patents.date.priority2006-09-28 US 11/848159Pen_US
patents.description.ccwoen_US
patents.identifier.publicationWO 2008040027en_US
patents.relation.familyUS 2008089874 (A1) 2008-04-17en_US
patents.description.kindA2en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats